{"id":16861,"date":"2021-10-20T08:20:41","date_gmt":"2021-10-20T15:20:41","guid":{"rendered":"https:\/\/drugpolicy.ca\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/"},"modified":"2021-11-02T14:14:53","modified_gmt":"2021-11-02T21:14:53","slug":"priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet","status":"publish","type":"post","link":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/","title":{"rendered":"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">La d\u00e9criminalisation des drogues b\u00e9n\u00e9ficie d\u2019un soutien accru de la population. Plus t\u00f4t cette ann\u00e9e, un sondage national a r\u00e9v\u00e9l\u00e9 que pr\u00e8s de 60 % des personnes r\u00e9pondantes, ainsi qu\u2019une majorit\u00e9 dans chaque province, \u00e9taient en faveur de la suppression des sanctions p\u00e9nales applicables \u00e0 la possession de drogue pour usage personnel. L\u2019ann\u00e9e derni\u00e8re, pr\u00e8s de 200 organisations \u00e0 l\u2019\u00e9chelle du Canada ont appuy\u00e9 un appel lanc\u00e9 \u00e0 des ministres cl\u00e9s du gouvernement f\u00e9d\u00e9ral pour que soit imm\u00e9diatement d\u00e9criminalis\u00e9e la possession simple de drogue.&#13;\n<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Au cours de ce nouveau mandat, nous vous demandons de prioriser une politique sur les drogues fond\u00e9e sur les donn\u00e9es probantes et d\u2019inclure la r\u00e9forme de la politique sur les drogues dans les mandats que vous confierez \u00e0 votre nouveau cabinet<\/strong><\/p>\n\n<iframe loading=\"lazy\" class=\"scribd_iframe_embed\" title=\"Lettre_Ouverte_PMO - October19 FINAL\" src=\"https:\/\/www.scribd.com\/embeds\/533946201\/content?start_page=1&#038;view_mode=scroll&#038;access_key=key-PkjkLyVBjhqfqEKg2PkN\" data-auto-height=\"false\" data-aspect-ratio=\"0.7729220222793488\" scrolling=\"no\" id=\"doc_41097\" width=\"100%\" height=\"600\" frameborder=\"0\"><\/iframe>\n\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-red-background-color has-text-color has-background\" href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2021\/10\/Lettre_Ouverte_PMO-October19-FINAL.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Telecharger<\/a><\/div>\n<\/div>\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<div class=\"widget signup-widget mb-5\">\r\n<p class=\"lead\"><strong>\u00cates-vous pr\u00eat(e) \u00e0 aider ?<\/strong><\/p>\r\n<p>Soutenez des politiques sur les drogues bas\u00e9es sur la justice sociale, la compassion et les preuves. Inscrivez-vous \u00e0 notre newsletter pour obtenir des mises \u00e0 jour et d\u00e9couvrez comment vous pouvez agir avec nous.<\/p>\r\n<!-- form.123formbuilder.com script begins here --><script type=\"text\/javascript\" defer=\"defer\" src=\"https:\/\/form.123formbuilder.com\/embed\/6415583.js\" data-role=\"form\" data-default-width=\"650px\"><\/script><!-- form.123formbuilder.com script ends here -->\r\n<\/div>\r\n","protected":false},"excerpt":{"rendered":"<p>Il n\u2019y a pas de temps \u00e0 perdre, car la pand\u00e9mie de COVID-19 continue d\u2019exacerber les crises de sant\u00e9 publique actuelles li\u00e9es aux blessures et aux d\u00e9c\u00e8s dus \u00e0 la toxicit\u00e9 des drogues, en plus des pand\u00e9mies de VIH et de VHC qui n\u2019ont toujours pas \u00e9t\u00e9 endigu\u00e9es, entre autres fl\u00e9aux.<\/p>\n","protected":false},"author":38,"featured_media":13137,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1117],"tags":[],"class_list":["post-16861","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-plaidoyer"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet - Canadian Drug Policy Coalition<\/title>\n<meta name=\"description\" content=\"Il n\u2019y a pas de temps \u00e0 perdre, car la pand\u00e9mie de COVID-19 continue d\u2019exacerber les crises de sant\u00e9 publique actuelles li\u00e9es aux blessures et aux d\u00e9c\u00e8s dus \u00e0 la toxicit\u00e9 des drogues, en plus des pand\u00e9mies de VIH et de VHC qui n\u2019ont toujours pas \u00e9t\u00e9 endigu\u00e9es, entre autres fl\u00e9aux.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Il n\u2019y a pas de temps \u00e0 perdre, car la pand\u00e9mie de COVID-19 continue d\u2019exacerber les crises de sant\u00e9 publique actuelles li\u00e9es aux blessures et aux d\u00e9c\u00e8s dus \u00e0 la toxicit\u00e9 des drogues, en plus des pand\u00e9mies de VIH et de VHC qui n\u2019ont toujours pas \u00e9t\u00e9 endigu\u00e9es, entre autres fl\u00e9aux.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-20T15:20:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-02T21:14:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1925\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Canadian Drug Policy Coalition\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/\"},\"author\":{\"name\":\"Canadian Drug Policy Coalition\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\"},\"headline\":\"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet\",\"datePublished\":\"2021-10-20T15:20:41+00:00\",\"dateModified\":\"2021-11-02T21:14:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/\"},\"wordCount\":160,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Centre_Block_-_Parliament_Hill-scaled.jpg\",\"articleSection\":[\"plaidoyer\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/\",\"name\":\"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Centre_Block_-_Parliament_Hill-scaled.jpg\",\"datePublished\":\"2021-10-20T15:20:41+00:00\",\"dateModified\":\"2021-11-02T21:14:53+00:00\",\"description\":\"Il n\u2019y a pas de temps \u00e0 perdre, car la pand\u00e9mie de COVID-19 continue d\u2019exacerber les crises de sant\u00e9 publique actuelles li\u00e9es aux blessures et aux d\u00e9c\u00e8s dus \u00e0 la toxicit\u00e9 des drogues, en plus des pand\u00e9mies de VIH et de VHC qui n\u2019ont toujours pas \u00e9t\u00e9 endigu\u00e9es, entre autres fl\u00e9aux.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/#primaryimage\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Centre_Block_-_Parliament_Hill-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Centre_Block_-_Parliament_Hill-scaled.jpg\",\"width\":2560,\"height\":1925,\"caption\":\"Parliament Hill building in Ottawa\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\",\"name\":\"Canadian Drug Policy Coalition\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"caption\":\"Canadian Drug Policy Coalition\"},\"description\":\"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/author\\\/canadian-drug-policy-coalition\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet - Canadian Drug Policy Coalition","description":"Il n\u2019y a pas de temps \u00e0 perdre, car la pand\u00e9mie de COVID-19 continue d\u2019exacerber les crises de sant\u00e9 publique actuelles li\u00e9es aux blessures et aux d\u00e9c\u00e8s dus \u00e0 la toxicit\u00e9 des drogues, en plus des pand\u00e9mies de VIH et de VHC qui n\u2019ont toujours pas \u00e9t\u00e9 endigu\u00e9es, entre autres fl\u00e9aux.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/","og_locale":"fr_FR","og_type":"article","og_title":"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet - Canadian Drug Policy Coalition","og_description":"Il n\u2019y a pas de temps \u00e0 perdre, car la pand\u00e9mie de COVID-19 continue d\u2019exacerber les crises de sant\u00e9 publique actuelles li\u00e9es aux blessures et aux d\u00e9c\u00e8s dus \u00e0 la toxicit\u00e9 des drogues, en plus des pand\u00e9mies de VIH et de VHC qui n\u2019ont toujours pas \u00e9t\u00e9 endigu\u00e9es, entre autres fl\u00e9aux.","og_url":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2021-10-20T15:20:41+00:00","article_modified_time":"2021-11-02T21:14:53+00:00","og_image":[{"width":2560,"height":1925,"url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg","type":"image\/jpeg"}],"author":"Canadian Drug Policy Coalition","twitter_card":"summary_large_image","twitter_image":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg","twitter_misc":{"\u00c9crit par":"Canadian Drug Policy Coalition","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/#article","isPartOf":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/"},"author":{"name":"Canadian Drug Policy Coalition","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30"},"headline":"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet","datePublished":"2021-10-20T15:20:41+00:00","dateModified":"2021-11-02T21:14:53+00:00","mainEntityOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/"},"wordCount":160,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg","articleSection":["plaidoyer"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/","url":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/","name":"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/#primaryimage"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg","datePublished":"2021-10-20T15:20:41+00:00","dateModified":"2021-11-02T21:14:53+00:00","description":"Il n\u2019y a pas de temps \u00e0 perdre, car la pand\u00e9mie de COVID-19 continue d\u2019exacerber les crises de sant\u00e9 publique actuelles li\u00e9es aux blessures et aux d\u00e9c\u00e8s dus \u00e0 la toxicit\u00e9 des drogues, en plus des pand\u00e9mies de VIH et de VHC qui n\u2019ont toujours pas \u00e9t\u00e9 endigu\u00e9es, entre autres fl\u00e9aux.","breadcrumb":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/#primaryimage","url":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg","contentUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2019\/11\/Centre_Block_-_Parliament_Hill-scaled.jpg","width":2560,"height":1925,"caption":"Parliament Hill building in Ottawa"},{"@type":"BreadcrumbList","@id":"https:\/\/new.drugpolicy.ca\/fr\/priorite-a-la-politique-en-matiere-de-drogues-pour-les-nouveaux-membres-du-cabinet\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Priorit\u00e9 \u00e0 la politique en mati\u00e8re de drogues pour les nouveaux membres du cabinet"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30","name":"Canadian Drug Policy Coalition","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","caption":"Canadian Drug Policy Coalition"},"description":"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice","url":"https:\/\/new.drugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/16861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=16861"}],"version-history":[{"count":12,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/16861\/revisions"}],"predecessor-version":[{"id":16891,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/16861\/revisions\/16891"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/13137"}],"wp:attachment":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=16861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=16861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=16861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}